20 May 2013
Keywords: ph, iii, trovax, trial, gets, dsmb, ok
Article | 30 July 2007
UK biopharmaceutical company Oxford BioMedica says that the independent Data Safety Monitoring Board observing the ongoing Phase III TRIST study
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 July 2007
17 May 2013
© 2013 thepharmaletter.com